Potential Link Between Smoking, Vaping, and Increased Diabetes Risk
New research links smoking and vaping to higher risks of prediabetes and diabetes, emphasizing the need for public health efforts to reduce tobacco and e-cigarette use.
Recent research from the University of Georgia indicates that both smoking traditional cigarettes and vaping with e-cigarettes may significantly elevate the risk of developing prediabetes and diabetes. The study analyzed data from over 1.2 million participants, revealing that individuals who use e-cigarettes are 7% more likely to develop prediabetes, while traditional smokers face a 15% increased risk. Those who indulge in both habits simultaneously face the highest risk, with a 28% greater chance of developing prediabetes. Furthermore, users of both products also show increased odds of being diagnosed with diabetes,
highlighting the compounded health dangers.
The research emphasizes that e-cigarettes, often marketed as a safer alternative to smoking, may conceal hidden health risks, particularly affecting metabolic health and insulin resistance. The findings are especially concerning among vulnerable groups such as Hispanic, Black, and lower-income populations, who exhibit higher susceptibility.
Additional factors aggravating the risk include being overweight or obese, with heavier body mass index correlating with worse outcomes. Regular physical activity was found to reduce the risk of prediabetes by 8%, suggesting lifestyle modifications could mitigate some adverse effects.
These insights underscore the importance of public health initiatives aimed at reducing tobacco and e-cigarette use to curb the rising prevalence of diabetes and improve overall metabolic health.
Source: https://medicalxpress.com/news/2025-09-vaping-diabetes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Mouse Models for Ultra-Rare Neurological Disorder Could Accelerate Gene Therapy Development
Researchers at Jackson Laboratory have developed new mouse models to study rare neurological disorder AHC, paving the way for potential gene editing therapies and improved understanding of disease mechanisms.
Discovery of PROX1 Gene as an Early Indicator of Aggressive Prostate Cancer
A groundbreaking study by the University of Michigan has identified the PROX1 gene as an early driver of aggressive, treatment-resistant prostate cancer. Targeting PROX1 with existing HDAC inhibitors may offer new therapeutic options for advanced prostate cancer patients.
Record High Valley Fever Cases Reported in California in 2025
California reports a sharp rise in valley fever cases in 2025, with a record-breaking number of infections linked to climate and environmental factors. Stay informed to protect yourself.
